$79.99
Research Studies:
Out of stock
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Thymosin Alpha-1 5mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Thymosin Alpha-1 5mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 62304-98-7 |
|---|---|
| Purity | ≥99% |
| Sequence | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn |
| Molecular Formula | C129H215N33O55 |
| Molecular Weight | 3108.3 g/mol |
| Applications | Immune modulation, antiviral research, immunotherapy studies |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy Thymosin Alpha-1 online should evaluate Thymosin Alpha-1 as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate Thymosin Alpha-1 for controlled research procurement through Pure Lab Peptides, with emphasis on supplier documentation, analytical transparency, and RUO boundaries.
Researchers can buy Thymosin Alpha-1 online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. The evaluation should center on documents, labels, and lot records rather than any use outcome.
The phrase “buy Thymosin Alpha-1 online” is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the searcher is a qualified researcher, laboratory buyer, research institution, or technical procurement team comparing RUO materials for controlled laboratory settings.
Research procurement is a documentation-first process. A laboratory buyer should verify that a supplier’s presentation is consistent with research-use-only positioning, that the product page avoids personal-use claims, and that batch-specific quality documentation is available for review. FDA guidance for RUO-labeled in vitro diagnostic products emphasizes the relationship between RUO labeling and intended use, and federal labeling language provides a useful compliance reference for research-only positioning even when a peptide material is not being presented as an IVD product [1] [2].
For Thymosin Alpha-1 research-use-only procurement, the buyer’s review should include the product name, fill size, product form, lot number, COA status, testing method, purity result, identity documentation, storage information, and supplier transparency. The goal is not to infer product effects. The goal is to confirm that the Thymosin Alpha-1 research material is labeled, documented, and traceable enough for laboratory recordkeeping.
Thymosin Alpha-1 is commonly discussed in scientific databases under the name thymalfasin. PubChem identifies thymalfasin as an acetylated polypeptide with molecular formula C129H215N33O55, and ChEMBL maintains a compound record for thymalfasin under CHEMBL2103979 [3] [4]. Researchers evaluating Thymosin Alpha-1 identity testing should compare supplier documentation against the compound name, molecular identity, and analytical data presented for the relevant lot.
The compound has a long literature history. A 1977 PNAS paper reported isolation and sequence analysis of thymosin alpha1 as a 28-amino-acid thymic polypeptide, while a later Journal of Biological Chemistry paper described detailed amino acid sequence analysis and N-terminal acetylation [5] [6]. In laboratory documentation, this kind of identity context is relevant because peptide materials are typically characterized through a combination of name, sequence or molecular description, molecular mass, chromatographic profile, and mass-based confirmation.
Thymosin Alpha-1 also appears in prothymosin alpha literature. Prothymosin alpha was isolated as an immunoreactive form related to thymosin alpha1, and later research described processing of prothymosin alpha to thymosin alpha1 and thymosin alpha11 by an asparaginyl endopeptidase [7] [8]. NCBI Gene and UniProt records identify PTMA as the human gene/protein entry for prothymosin alpha, which is useful for scientific context but should not be converted into a product-use claim for any RUO material [9] [10].
For category purposes, Thymosin Alpha-1 is best treated as a thymosin-related research peptide with immunology and peptide-characterization literature. Because the supplied category rules do not provide a dedicated Thymosin Alpha-1 category, this guide applies conservative general RUO boundaries: compound identity, analytical documentation, COA review, lot traceability, and supplier transparency. Published thymosin-related literature should be discussed as scientific context, not as product-use guidance for RUO materials.
Researchers search “buy Thymosin Alpha-1 online” when they need to evaluate research-use-only product availability and supplier documentation before procurement. This is a technical purchasing task, not a consumer decision. The most relevant questions are whether the material is labeled for research use only, whether the supplier makes a batch-specific Thymosin Alpha-1 COA available, and whether the product page clearly identifies the material as a laboratory research compound.
Teams that buy Thymosin Alpha-1 for laboratory research should also check whether documentation connects the product name, amount, lot number, product form, and analytical method. A Thymosin Alpha-1 COA should be reviewed with the label and product page so discrepancies can be detected before the material enters laboratory records.
Search intent is also practical. Procurement teams may need a Thymosin Alpha-1 research-use-only source with transparent Thymosin Alpha-1 purity documentation, Thymosin Alpha-1 identity testing, and Thymosin Alpha-1 supplier documentation. These terms point to traceability, not personal-use outcomes. Buying intent is appropriate only when it is qualified as buy Thymosin Alpha-1 online for laboratory research.
Researchers evaluating where to buy Thymosin Alpha-1 online should look for quality signals that support laboratory recordkeeping. The strongest procurement signals are not marketing claims. They are specific, reviewable documents that connect a product page, label, lot number, and COA.
| Quality signal | What researchers should review | Why it matters for RUO procurement |
| RUO labeling | Research-use-only language on product presentation and supporting documentation | Clarifies that the material is positioned for laboratory research, not personal use |
| Batch-specific COA | COA tied to the product lot rather than a generic sample document | Supports lot-level traceability and laboratory documentation |
| Purity documentation | Purity result, testing method, and chromatographic or analytical basis | Helps researchers evaluate whether the reported purity is supported by data |
| Identity testing | Molecular identity, mass data, sequence context, or equivalent method | Reduces reliance on product name alone |
| Lot consistency | Matching lot number across product label, COA, and internal receiving records | Links documentation to the exact research material received |
| Product form | Lyophilized powder form and storage information | Supports controlled inventory and handling records |
Thymosin Alpha-1 purity documentation should be reviewed as one part of a broader identity and traceability file. A strong review looks for the compound name, lot number, test date, purity percentage, analytical method, identity confirmation, molecular weight where relevant, product form, and storage documentation. A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together.
Analytical documentation practices are supported by broader method-validation and laboratory-quality sources. FDA guidance discusses analytical procedures and validation data for documenting identity, strength, quality, purity, and related attributes; ICH Q2(R2) addresses validation of analytical procedures; ICH Q14 addresses analytical procedure development; and ISO/IEC 17025 addresses competent testing and calibration laboratory operation [11] [12] [13] [14]. USP reference-standard guidance and NIST reference-material resources also illustrate why assigned values, certificates, and traceable measurement records matter in laboratory documentation [15] [16].
For peptide materials, HPLC is widely used in peptide analysis and purification, while mass spectrometry is a core method for peptide and protein analysis because it can support molecular-mass and identification workflows [17] [18]. Thymosin Alpha-1 has also appeared in analytical literature using LC-MS/MS, which shows the relevance of mass-based analytical methods to this compound’s scientific record without implying any RUO product-use guidance [19].
This workflow is a documentation review model. It does not describe preparation, administration, dosing, or any use protocol. The purpose is to help laboratory teams decide whether Thymosin Alpha-1 supplier documentation is complete enough for controlled research procurement records.
Published literature has examined Thymosin Alpha-1 across biochemical, immunology-related, analytical, preclinical, review-based, and clinical study settings. Reviews have summarized the compound’s historical development, biological research context, and laboratory models involving thymosin-related pathways [20] [21] [22]. This literature can help researchers understand why the compound appears in scientific databases and published model systems, but it should not be treated as a claim about any RUO product.
Some research literature discusses immunology-related signaling, dendritic-cell models, cytokine-model observations, and thymosin-related history [23] [24]. Other reviews discuss infectious-disease research areas or in vitro experimental systems involving Thymosin Alpha-1 [25] [26]. These citations provide research context only. They do not establish that a research-use-only Thymosin Alpha-1 material is appropriate for human use, animal use, diagnostic use, therapeutic use, or any clinical purpose.
Published clinical literature should not be interpreted as use guidance for RUO materials. Regulated clinical products, study protocols, and RUO laboratory materials are not interchangeable. This article discusses research-use-only sourcing and documentation, not clinical use.
| Evidence type | What it can support | What it cannot support for RUO procurement |
| Database records | Compound name, identifiers, formula, and database classification context | They do not replace a batch-specific Thymosin Alpha-1 COA |
| Historical sequence literature | Scientific background on peptide identity and sequence characterization | It does not verify the identity of a supplier’s current lot |
| Analytical-method literature | General relevance of HPLC, LC-MS, and mass spectrometry to peptide characterization | It does not prove that a supplier performed a specific method unless documented |
| Review literature | Broad scientific context and limitations across published studies | It does not convert published findings into RUO product-use guidance |
| In vitro and preclinical literature | Model-based context under defined experimental conditions | It does not justify personal-use, animal-use, clinical, or diagnostic claims |
| Clinical literature outside RUO scope | Historical context for regulated research and study design | It does not apply to research-use-only materials sold for laboratory procurement |
| Acceptable research phrasing | Unsafe product claim to avoid |
| “Thymosin Alpha-1 appears in thymosin-related research literature.” | “Thymosin Alpha-1 produces personal health results.” |
| “Researchers should review Thymosin Alpha-1 COA and identity testing before procurement.” | “A purity percentage alone proves the product’s full identity.” |
| “Published literature provides scientific context for controlled laboratory research.” | “Published studies are instructions for using an RUO material.” |
| “Thymosin Alpha-1 research-use-only material should be documented by lot.” | “RUO labeling supports human, animal, clinical, or diagnostic use.” |
| “Supplier transparency includes labeling, COA availability, and lot-level traceability.” | “Supplier claims can replace analytical documentation.” |
Pure Lab Peptides presents Thymosin Alpha-1 5mg as a research-use-only laboratory material. The product is listed in lyophilized powder form with an ≥99% purity claim, and a batch-specific COA is available for documentation review. Laboratory buyers should review the product page, COA, product labeling, storage and handling documentation, and lot-level traceability before adding the material to internal procurement records.
Review the Pure Lab Peptides Thymosin Alpha-1 research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. Researchers comparing available peptide materials can also review the broader Pure Lab Peptides research peptide collection for supplier presentation, documentation consistency, and research-only positioning.
In this article, “buy Thymosin Alpha-1 online” means laboratory research procurement. The phrase does not refer to personal-use intent, consumer decision-making, wellness use, therapeutic use, or any form of self-directed use. Qualified laboratory buyers should evaluate RUO labeling, COA availability, identity documentation, and supplier transparency.
Published thymosin-related literature is scientific context. It is not a protocol, instructions, or product-use guidance for an RUO material. Research model findings are bound to their study design, materials, controls, and regulatory context. They should not be transferred to a commercial research material as a product claim.
Purity is important, but it is not the same as full identity confirmation. Researchers should review the Thymosin Alpha-1 COA with the product name, lot number, analytical method, identity testing, molecular information, and product form. A purity value without method and identity context is incomplete for research procurement review.
A generic COA is weaker than batch-specific documentation because it may not correspond to the actual lot received by the laboratory. For Thymosin Alpha-1 supplier documentation, the lot number on the COA should match the product label and internal receiving records.
RUO labeling does not support clinical, diagnostic, veterinary, personal, or consumer positioning. A research-use-only label is a boundary for controlled laboratory research. Laboratory teams should reject supplier content that mixes RUO materials with personal-use claims, protocols, or outcome language.
Researchers can buy Thymosin Alpha-1 online for laboratory research from an RUO supplier that provides clear product labeling, batch-specific COA access, purity documentation, identity information, storage guidance, and lot-level traceability. Pure Lab Peptides provides a Thymosin Alpha-1 5mg product page for research-use-only procurement review.
Before buying Thymosin Alpha-1 online, researchers should check RUO labeling, product name consistency, lot number matching, COA availability, purity documentation, identity testing, product form, storage information, and supplier transparency. The review should focus on documentation quality, not personal-use expectations.
A COA matters when buying Thymosin Alpha-1 because it gives laboratory buyers a lot-specific record to compare against the product label and internal receiving records. Researchers should review the Thymosin Alpha-1 COA for compound name, lot number, purity data, analytical method, identity support, and documentation consistency.
No. Thymosin Alpha-1 research-use-only material discussed here is not intended for human or animal consumption. RUO procurement language means the material is positioned for controlled laboratory research. It should not be described as a consumer product, clinical product, diagnostic product, veterinary material, or therapeutic material.
Research use only means Thymosin Alpha-1 is presented as a laboratory research material for qualified research settings. The phrase defines procurement and labeling boundaries. Researchers should evaluate documentation, COA status, identity testing, purity records, and lot traceability, while avoiding any interpretation connected to personal or clinical use.
Published literature about Thymosin Alpha-1 should be interpreted as scientific background for researchers, not as instructions or claims for an RUO product. Study findings depend on the materials, controls, endpoints, and regulatory context of each publication. Published clinical literature should not be interpreted as use guidance for RUO materials.
For research teams comparing Thymosin Alpha-1 suppliers, prioritize COA availability, transparent labeling, purity documentation, identity testing, storage information, and lot-level traceability. Review the Thymosin Alpha-1 product page for RUO labeling, product details, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.